These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5868998)

  • 21. [Comparative assessment of the effect of donor blood and its components on the blood coagulation system of the recipient].
    Chistiakov VA; Belitskaia GA
    Vrach Delo; 1966 Jul; 7():39-41. PubMed ID: 5990715
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the pathogenesis and therapy of experimental afibrinogenemia].
    Chernaia VV
    Patol Fiziol Eksp Ter; 1967; 11(2):41-5. PubMed ID: 5619199
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacological research on derivatives of epsilon-aminocaproic acid. I. Action on the cardiovascular system of 3-4-5-trimethoxy-benzoyl-epsilon-aminocaproci acid].
    Razzaboni G; Setti L; Tamiso R
    Boll Soc Ital Biol Sper; 1968 Nov; 44(21):1783-5. PubMed ID: 5733068
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of therapeutic effect of epsilon-aminocaproic acid in acute radiation sickness of dogs].
    Luzanova OV; Rogacheva SA
    Med Radiol (Mosk); 1974 Nov; 19(11):18-23. PubMed ID: 4437326
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacodynamic study of a fibrinolytic inhibitor: epsilon-aminocaproic acid].
    Foussard-Blanpin O; Bretaudeau J
    Anesth Analg (Paris); 1965; 22(3):481-513. PubMed ID: 5847919
    [No Abstract]   [Full Text] [Related]  

  • 26. Clot lysis in a perfusion system.
    Bouvier CA; Gruendlinger J; Berthoud S
    Thromb Diath Haemorrh; 1966 Jan; 15(1):205-19. PubMed ID: 5919801
    [No Abstract]   [Full Text] [Related]  

  • 27. [Afibrinogenemia with fatal outcome after Billroth II surgery].
    Bartel W
    Zentralbl Chir; 1966 Nov; 91(47):1761-4. PubMed ID: 5300499
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epsilon-aminocaproic acid as an immunosuppressive agent in a homologous experimental kidney transplantation].
    Tamames S; Sánchez Vera M; Gómez Sánchez J
    Rev Clin Esp; 1968 Apr; 109(1):17-20. PubMed ID: 4903280
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of indwelling polyethylene catheters on the elimination of 125 I-fibrinogen in dogs.
    Zetterqvist E; Carlson LA; Liljedahl SO
    Bibl Anat; 1969; 10():458-63. PubMed ID: 5407400
    [No Abstract]   [Full Text] [Related]  

  • 30. [Urinary incidents in the treatment of hematuria in hemophiliacs with epsilon-aminocaproic acid].
    Goudemand M; Parquet-Gernez A; Deconninck B
    Lille Med; 1968 Apr; 13(4):408-12. PubMed ID: 5684775
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thrombelastographic evaluation of blood coagulation in acute myocardial infarct treated with 3,4,5 trimethoxybenzoylaminocaproate sodium].
    Zangara A; Dugoni D; Anselmi L
    Minerva Med; 1973 Mar; 64(16):803-11. PubMed ID: 4723563
    [No Abstract]   [Full Text] [Related]  

  • 32. Fibrinolysis vs disseminated intravascular coagulation.
    Charytan C
    N Engl J Med; 1969 Jul; 281(4):222. PubMed ID: 5790515
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of epsilon-aminocaproic acid administered to parturient women on the blood coagulation system of the newborn].
    Budyka LA
    Vopr Okhr Materin Det; 1968 Jan; 13(1):31-4. PubMed ID: 5719518
    [No Abstract]   [Full Text] [Related]  

  • 34. [Continuous invisible blood coagulation and fibrinolysis in normal and pathological states].
    Oyvin IA; Islamov II
    Thromb Diath Haemorrh; 1972 Feb; 27(1):173-8. PubMed ID: 5033666
    [No Abstract]   [Full Text] [Related]  

  • 35. Differentiation between plasminogen activators by means of epsilon-aminocaproic acid.
    Kok P; Astrup T
    Thromb Diath Haemorrh; 1972 Feb; 27(1):77-87. PubMed ID: 4260740
    [No Abstract]   [Full Text] [Related]  

  • 36. [Inhibiting action of epsilon-aminocaproic acid on arrhythmias induced by administration of calcium chloride in rats].
    Agliati G; Conti F; Laveneziana D; Pelosi G
    Boll Soc Ital Biol Sper; 1968 Nov; 44(21):1822-3. PubMed ID: 5733080
    [No Abstract]   [Full Text] [Related]  

  • 37. [The action of epsilon-aminocaproic acid (EACA) on delayed allergic reactions].
    Tortoli V; Palchetti R; Giunta A
    Riv Crit Clin Med; 1965 Oct; 65(5):565-72. PubMed ID: 5885543
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of the mechanism of hypotension induced in certain conditions by epsilon-aminocaproic acid].
    Foussard-Blanpin O; Bretaudeau J
    C R Seances Soc Biol Fil; 1966; 160(3):641-6. PubMed ID: 4380833
    [No Abstract]   [Full Text] [Related]  

  • 39. Congenital afibrinogenemia. A case report and therapeutic trials.
    Ozsoylu S; Altay C; Corbacioğlu B
    Turk J Pediatr; 1966 Jan; 8(1):29-35. PubMed ID: 5916625
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anti-bradykininase activity in vitro of episilon-aminocaproic acid and epsilon-benzoyl-aminocaproic acid].
    Castelli M
    Boll Soc Ital Biol Sper; 1967 Jul; 43(13):803-7. PubMed ID: 6069714
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.